Drug ID: | NPD4534 |
Drug Name: | BM-13.1180 |
Molecular Formula: | C21H25ClO3 |
Canonical SMILES: | OC(=O)C(Oc1ccc(cc1)C(C)(C)C)CCCc1ccc(cc1)Cl |
Standard InCHI: | InChI=1S/C21H25ClO3/c1-21(2,3)16-9-13-18(14-10-16)25-19(20(23)24)6-4-5-15-7-11-17(22)12-8-15/h7-14,19H,4-6H2,1-3H3,(H,23,24) |
Standard InCHIKey: | CUDNHZMBOHDPIO-UHFFFAOYSA-N |
Max Developmental Stage: | Discontinued |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB011574 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 360.15 |
ALogP | 1.2359 |
MLogP | 3.33 |
XLogP | 7.921 |
HDA | 2 |
HBD | 1 |
Rotatable Bonds | 13 |
TPSA | 46.53 |
RO5 Violation | 1 |